🇺🇸 Chondroitin in United States

9,330 US adverse-event reports

Marketing authorisation

FDA

• Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 27 March 2025 – 27 March 2026
• Total reports: 9,330

Most-reported reactions

1. Fatigue — 1,414 reports (15.16%)
2. Nausea — 966 reports (10.35%)
3. Arthralgia — 954 reports (10.23%)
4. Diarrhoea — 948 reports (10.16%)
5. Pain — 944 reports (10.12%)
6. Drug Ineffective — 907 reports (9.72%)
7. Headache — 873 reports (9.36%)
8. Dizziness — 798 reports (8.55%)
9. Dyspnoea — 765 reports (8.2%)
10. Fall — 761 reports (8.16%)

Source database →

Frequently asked questions

Is Chondroitin approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Chondroitin in United States?

National Center for Complementary and Integrative Health (NCCIH) is the originator. The local marketing authorisation holder may differ — check the official source linked above.